The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 Trial
双位阻 mTORC1 选择性抑制剂 RMC-5552 在晚期实体瘤中的应用:一项 1 期临床试验
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-2112
Schram, Alison M; Naqash, Abdul Rafeh; Haura, Eric B; Riess, Jonathan W; Ulahannan, Susanna V; Ou, Sai-Hong I; Munster, Pamela N; Cheng, Michael L; Gustafson, W Clay; Bitman, Bojena; Friedman, Robert; Penn, Ruth; Kar, Sumit; Seshadri, Vidya; Wang, Zhican; Tao, Lin; Yang, Yu Chi; Singh, Mallika; Burris, Howard A; Meyerowitz, Justin G